Differential effect of transdermal estrogen plus progestagen replacement therapy on insulin metabolism in postmenopausal women: Relation to their insulinemic secretion

European Journal of Endocrinology

Volumn 140, Issue 3, 1999, Pages 215-223

  Cucinelli, Francesco ^a   Paparella, Pierluigi ^a   Soranna, Liberato ^a   Barini, Angela ^a   Cinque, Biagio ^a   Mancuso, Salvatore ^a   Lanzone, Antonio ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; C PEPTIDE; CHOLESTEROL; DYDROGESTERONE; EPIESTROL 50; ESTRADIOL; ESTROGEN; ESTRONE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRASTERONE SULFATE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; DRUG MECHANISM; FEMALE; GLUCOSE METABOLISM; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INSULIN SENSITIVITY; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; POSTMENOPAUSE; PRIORITY JOURNAL; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0032942951     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1400215     Document Type: Article

References (25)

1. Buchler D & Warren JC. Effects of estrogen on glucose tolerance. American Journal of Obstetrics and Gynecology 1966 95 479-483.
2. Spellacy WN, Buhi WC & Birk SA. The effect of estrogen on carbohydrate metabolism: glucose, insulin, and growth hormone studies on one hundred and seventy-one women ingesting Premarin. mestranol, and ethinyl estradiol for six months. American Journal of Obstetrics and Gynecology 1972 114 378-392.
3. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the postmenopausal estrogen/progestin interventions (PEPI) Trial. Journal of the American Medical Association 1995 273 199-208.
4. Cagnacci A, Soldani R, Carriero PL, Paoletti AM, Fioretti P, Melis GB et al. Effect of low doses of transdermal 17β-estradiol on carbohydrate metabolism in postmenopausal women. Journal of Clinical Endocrinology 1992 74 1396-1400.
5. Lindheim SR, Presser SC, Ditkoff EC, Vijod MA, Stanczyk FZ, Lobo RA. A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin. Fertility and Sterility 1993 60 664-667.
6. O'Sullivan A & HO Ken KY. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 1995 80 1783-1788.
7. Sutter-Dub MT, Dazey B, Hamdan E & Vergnaud MT. Progesterone and insulin-resistance: studies of progesterone action on glucose transport lipogenesis and lipolysis in isolated fat cells of the female rat. Journal of Endocrinology 1981 88 455-462.
8. Grodstein F, Stampfer MJ, Manson JAE, Colditz GA, Willet WC, Rosner B et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. New England Journal of Medicine 1996 335 453-461.
9. Chetkowski RJ, Meldrum DR & Steingold KA. Biological effect of transdermal estradiol. New England Journal of Medicine 1986 314 1615-1620.
10. De Fronzo RA, Tobin JD & Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. American Journal of Physiology 1979 237 214-223.
11. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979 28 1039-1057.
12. Lanzone A, Fulghesu AM, Fortini A, Cutillo G, Cucinelli F, Di Simone N, Caruso A et al. Effect of opiate receptor blockade on the insulin response to oral glucose load in polycystic ovarian disease. Human Reproduction 1991 6 1043-1049.
13. Bonadonna RC, Groop L & Kraemer N. Obesity and insulin resistance in humans: a dose response study. Metabolism 1990 39 452-459.
14. Faber OK, Christensen K & Ketlem H. Decreased insulin removal contributes to hyperinsulinemia in obesity. Journal of Clinical Endocrinology and Metabolism 1981 53 618-621.
15. Bergman RN, Finegood DT & Ader M. Assessment of insulin sensitivity in vivo. Endocrine Reviews 1985 6 45-75.
16. Walsh BW, Shiff I, Rosner B, Greemberg L, Rawnikar W & Shacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. New England Journal of Medicine 1991 325 1196-1204.
17. Lobo RA. Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 1991 73 925-930.
18. Jensen J, Riis BJ, Strom V, Nilas L & Christiansen G. Long term effects of percutaneous estrogen and oral progesterone on serum lipoprotein in postmenopausal women. American Journal of Obstetrics and Gynecology 1987 156 66-71.
19. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988 37 1595-1607.
20. Hjortland MC, McNamara PM & Kannel WB. Some atherogenic concomitants of the menopause. The Framingham study. American Journal of Epidemiology 1976 103 304-311.
21. Matthews K, Meilahn E, Kuller L, Kelsey S, Caggiula A & Wing R. Menopause and risk factors for coronary heart disease. New England Journal of Medicine 1989 321 641-646.
22. Walton C, Godsland I, Proudler A, Wynn V & Stevenson CJ. The effects of menopause on insulin sensitivity, secretion and elimination in nonobese healthy women. European Journal of Clinical Investigation 1993 23 466-473.
23. Godsland IF, Crook D, Stevenson JC, Collins P, Rosano GMC, Less B, Sidhu M et al. The insulin resistance syndrome in postmenopausal women with cardiological syndrome X. British Heart Journal 1995 74 47-52.
24. Lobo RA, Pickar JH, Wild RA, Walsh B & Hirvinen E. Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. Obstetrics and Gynecology 1994 84 987-995.
25. The Cleyn K, Buytaert P & Coppens M. Carboydrate metabolism during hormonal sobstitution therapy. Maturitas 1989 11 235-242.